7MTX
Crystal Structure of the Catalytic Domain of the Inosine Monophosphate Dehydrogenase from Bacillus anthracis in the complex with IMP and the inhibitor P176
Replaces: 5URRSummary for 7MTX
| Entry DOI | 10.2210/pdb7mtx/pdb |
| Related | 3TSB 3TSD 3USB 4MJM 4MY1 4MY8 4MY9 4MYA 4MYX 4QM1 5URS 7MTU |
| Descriptor | Inosine-5'-monophosphate dehydrogenase, INOSINIC ACID, N-{2-chloro-5-[({2-[3-(prop-1-en-2-yl)phenyl]propan-2-yl}carbamoyl)amino]phenyl}-beta-D-ribopyranosylamine, ... (5 entities in total) |
| Functional Keywords | impdh, tim barrel, delta cbs, structural genomics, center for structural genomics of infectious diseases, csgid, oxidoreductase, oxidoreductase-oxidoreductase inhibitor complex |
| Biological source | Bacillus anthracis More |
| Total number of polymer chains | 8 |
| Total formula weight | 332582.74 |
| Authors | Kim, Y.,Maltseva, N.,Makowska-Grzyska, M.,Gu, M.,Gollapalli, D.,Hedstrom, L.,Anderson, W.F.,Joachimiak, A.,Center for Structural Genomics of Infectious Diseases (CSGID) (deposition date: 2021-05-13, release date: 2021-06-09, Last modification date: 2026-03-25) |
| Primary citation | Modi, G.,Marqus, G.M.,Vippila, M.R.,Gollapalli, D.R.,Kim, Y.,Manna, A.C.,Chacko, S.,Maltseva, N.,Wang, X.,Cullinane, R.T.,Zhang, Y.,Kotler, J.L.M.,Kuzmic, P.,Zhang, M.,Lawson, A.P.,Joachimiak, A.,Cheung, A.,Snider, B.B.,Rothstein, D.M.,Cuny, G.D.,Hedstrom, L. The Enzymatic Activity of Inosine 5'-Monophosphate Dehydrogenase May Not Be a Vulnerable Target for Staphylococcus aureus Infections. Acs Infect Dis., 7:3062-3076, 2021 Cited by PubMed Abstract: Many bacterial pathogens, including , require inosine 5'-monophosphate dehydrogenase (IMPDH) for infection, making this enzyme a promising new target for antibiotics. Although potent selective inhibitors of bacterial IMPDHs have been reported, relatively few have displayed antibacterial activity. Here we use structure-informed design to obtain inhibitors of IMPDH (IMPDH) that have potent antibacterial activity (minimal inhibitory concentrations less than 2 μM) and low cytotoxicity in mammalian cells. The physicochemical properties of the most active compounds were within typical Lipinski/Veber space, suggesting that polarity is not a general requirement for achieving antibacterial activity. Five compounds failed to display activity in mouse models of septicemia and abscess infection. Inhibitor-resistant strains readily emerged . Resistance resulted from substitutions in the cofactor/inhibitor binding site of IMPDH, confirming on-target antibacterial activity. These mutations decreased the binding of all inhibitors tested, but also decreased catalytic activity. Nonetheless, the resistant strains had comparable virulence to wild-type bacteria. Surprisingly, strains expressing catalytically inactive IMPDH displayed only a mild virulence defect. Collectively these observations question the vulnerability of the enzymatic activity of IMPDH as a target for the treatment of infections, suggesting other functions of this protein may be responsible for its role in infection. PubMed: 34590817DOI: 10.1021/acsinfecdis.1c00342 PDB entries with the same primary citation |
| Experimental method | X-RAY DIFFRACTION (2.44 Å) |
Structure validation
Download full validation report






